rs199588981

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP3BP6BS1BS2

The NM_004006.3(DMD):ā€‹c.2291A>Gā€‹(p.Asn764Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000196 in 1,209,195 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 87 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00021 ( 0 hom., 11 hem., cov: 22)
Exomes š‘“: 0.00020 ( 0 hom. 76 hem. )

Consequence

DMD
NM_004006.3 missense, splice_region

Scores

1
4
11
Splicing: ADA: 0.9979
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 4.11
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant X-32518009-T-C is Benign according to our data. Variant chrX-32518009-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 288446.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Benign=2, Uncertain_significance=1}. Variant chrX-32518009-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000206 (23/111913) while in subpopulation EAS AF= 0.00451 (16/3549). AF 95% confidence interval is 0.00283. There are 0 homozygotes in gnomad4. There are 11 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DMDNM_004006.3 linkuse as main transcriptc.2291A>G p.Asn764Ser missense_variant, splice_region_variant 18/79 ENST00000357033.9 NP_003997.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkuse as main transcriptc.2291A>G p.Asn764Ser missense_variant, splice_region_variant 18/791 NM_004006.3 ENSP00000354923 P4

Frequencies

GnomAD3 genomes
AF:
0.000206
AC:
23
AN:
111860
Hom.:
0
Cov.:
22
AF XY:
0.000323
AC XY:
11
AN XY:
34020
show subpopulations
Gnomad AFR
AF:
0.0000649
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000949
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00449
Gnomad SAS
AF:
0.000375
Gnomad FIN
AF:
0.000165
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000371
AC:
68
AN:
183211
Hom.:
0
AF XY:
0.000310
AC XY:
21
AN XY:
67717
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00375
Gnomad SAS exome
AF:
0.000105
Gnomad FIN exome
AF:
0.000187
Gnomad NFE exome
AF:
0.0000856
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000195
AC:
214
AN:
1097282
Hom.:
0
Cov.:
29
AF XY:
0.000210
AC XY:
76
AN XY:
362712
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000142
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00282
Gnomad4 SAS exome
AF:
0.000240
Gnomad4 FIN exome
AF:
0.000197
Gnomad4 NFE exome
AF:
0.000108
Gnomad4 OTH exome
AF:
0.000260
GnomAD4 genome
AF:
0.000206
AC:
23
AN:
111913
Hom.:
0
Cov.:
22
AF XY:
0.000323
AC XY:
11
AN XY:
34083
show subpopulations
Gnomad4 AFR
AF:
0.0000648
Gnomad4 AMR
AF:
0.0000948
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00451
Gnomad4 SAS
AF:
0.000377
Gnomad4 FIN
AF:
0.000165
Gnomad4 NFE
AF:
0.0000376
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000266
Hom.:
8
Bravo
AF:
0.000178
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.000338
AC:
41

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxApr 04, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 03, 2016- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2023DMD: PP3, BS2 -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteJan 23, 2017- -
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Likely benign, no assertion criteria providedclinical testingNatera, Inc.Aug 02, 2019- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 15, 2021This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Duchenne muscular dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.59
CADD
Pathogenic
28
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
.;T;.;.;T
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.94
D;.;D;D;T
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.0091
T;T;T;T;T
MetaSVM
Benign
-0.83
T
MutationTaster
Benign
0.97
N;N;N
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.62
.;N;.;N;N
REVEL
Benign
0.068
Sift
Benign
0.18
.;T;.;T;D
Sift4G
Uncertain
0.032
D;D;D;D;T
Polyphen
0.22, 0.39
.;B;.;.;B
Vest4
0.30
MVP
0.79
MPC
0.084
ClinPred
0.021
T
GERP RS
3.9
gMVP
0.086

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.90
SpliceAI score (max)
0.97
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.97
Position offset: 5

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199588981; hg19: chrX-32536126; API